Other languages Evoke Pharma, Inc.

Equities

EVOK

US30049G2030

Market Closed - Nasdaq Other stock markets 02:00:00 01/05/2024 am IST			5-day change	1st Jan Change
0.45 ^USD	+2.27%		+1.47%	-57.16%

24/04	Transcript : Evoke Pharma, Inc. - Special Call
21/03	Evoke Pharma, Inc. Announces Board Changes as of March 31, 2024	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Evoke Pharma, Inc. Announces Board Changes as of March 31, 2024	22/03
Evoke Pharma, Inc. Announces Chief Executive Officer Changes as of March 31, 2024	22/03
Evoke Pharma, Inc. Provides Earnings Guidance for 2024	15/03
Evoke Pharma, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	15/03
Evoke Pharma Prices Underwritten Public Offering	09/02
Evoke Pharma Says FDA Lists Latest US Patent for Gimoti in Orange Book	27/11
Evoke Pharma, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	09/11
Evoke Pharma, Inc. Provides Summary of Real-World Data on the Positive Impact of GIMOTI	01/11
Evoke Pharma, Inc. Enters into Sixth Amendment to Lease with SB Corporate Centre III-IV, LLC	13/23/13
Evoke Pharma, Inc. Receives Notice of Allowance from U.S. Patent and Trademark Office for GIMOTI	14/23/14
Evoke Pharma, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	10/23/10
Evoke Pharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	16/23/16
Evoke Pharma Patent Added To US FDA Orange Book Of Drug Products	01/23/01
Evoke Pharma, Inc. Announces United States Patent and Trademark Office Issues US Patent No. 11,628,150 Under the Title Nasal Formulations of Metoclopramide	21/23/21
Evoke Pharma Says US Patent and Trademark Office Grants Formulation Patent Covering GIMOTI Nasal Spray	20/23/20
Evoke Pharma's Q4 Loss per Share Narrows, Revenue Gains	22/23/22
Evoke Pharma, Inc. Provides Revenue Guidance for 2023	22/23/22
Evoke Pharma, Inc. Auditor Raises 'Going Concern' Doubt	21/23/21
Evoke Pharma, Inc. Announces Executive Changes	14/23/14
Evoke Pharma Says Joint Stipulation of Dismissal Filed in Gimoti Patent Infringement Case Involving Teva Pharmaceuticals	30/23/30

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Evoke Pharma, Inc.

Equities

EVOK

US30049G2030

Other languages

Filters